|
|
Other links at Articles > Internal Medicine |
| 4. |
New FDA Orphan Drugs: CDX-110, ATryn, ISIS 333611
|
|
|
The FDA has granted orphan drug designation to CDX-110 for the treatment of glioblastoma multiforme, ATryn for the treatment of hereditary antithrombin deficiency, and ISIS 333611 for the treatment of amyotrophic lateral sclerosis. Medscape Medical News
|
|
|